Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modular Biosurface Engineering of Magnetotactic Bacteria for Multimodal Synergistic Cancer Therapy.

Chem & bio engineering·2026
Same author

Toxicity of Biogenic Secondary Organic Aerosol toward Nerve Cells.

Chemical research in toxicology·2025
Same author

A polymer-free, tumor-microenvironment responsive sol-gel platform for spatiotemporal STING activation and self-amplifying immunotherapy.

Materials horizons·2025
Same author

MRI-Visualized Aqueous Microenvironment Engineering in 3D Hierarchical FePt Catalysts with Macroporous Architecture for Alkaline Hydrogen Evolution.

Nano letters·2025
Same author

Mechanisms and Therapeutic Strategies for Minority Cell-Induced Paclitaxel Resistance and Tumor Progression Mediated by Mechanical Forces.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Tumor Microenvironment-Responsive Magnetotactic Bacteria-Based Multi-Drug Delivery Platform for MRI-Visualized Tumor Photothermal Chemodynamic Therapy.

Biology·2024
Same journal

Ordered Polar Topological Domains Enabling Giant Second-Harmonic Generation in Ferroelectric Nematic Liquid Crystals.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Dual-Functional Alumina Additive Enabling Efficient, Volumetric Mechanoluminescence for Nighttime Safety Footwear.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Phase Transformation Accompanied by Evolution of Internal Stress and the Coupling Mechanism of Chemical-Mechanical Degradation in Single-Crystal NiRich Cathodes.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Zwitterionic Polymer Electrolytes With Dipole-Rotation-Assisted Ion Conduction for Solid Lithium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

3D-Printed Ultra-Thin Solid Polymer Electrolytes with Superior Dielectric Properties for Wide Temperature Range All-Solid-State Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Electrostatic Potential Tuning by Low-Volatility Halogenated Additive: Boosting PTQ10-Based Binary OPV to Near 20% Efficiency with High Scalability.

Advanced materials (Deerfield Beach, Fla.)·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.4K

G-Quadruplex-Modular CpG Nanoplatform Drives Multi-Pathway Immunity for Abscopal Chemoimmunotherapy.

Mengxue Sun1,2,3, Haoyuan Feng1,2, Xuefei Sun1,2

  • 1Beijing National Laboratory for Molecular Sciences (BNLMS), State Key Laboratory For Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.

Advanced Materials (Deerfield Beach, Fla.)
|March 25, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a novel nanoplatform for cancer immunotherapy, enhancing immune activation and overcoming tumor suppression. The innovative approach significantly boosts T cell response and reduces tumor growth with minimal toxicity.

Keywords:
G‐quadruplex CpGabscopal effectchemoimmunotherapymulti‐pathway immune activationtumor microenvironment reprogramming

More Related Videos

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

468
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

2.0K

Related Experiment Videos

Last Updated: Mar 27, 2026

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.4K
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

468
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

2.0K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Immunology

Background:

  • Conventional cancer immunotherapy faces challenges like weak immune activation, immunosuppressive tumor microenvironments (TME), and rapid CpG adjuvant degradation.
  • Existing treatments often fail to achieve sustained immune responses or effectively overcome tumor-induced immune suppression.

Purpose of the Study:

  • To develop a G-quadruplex (G4)-modular CpG nanoplatform (IONP-G4-DOX/IMT) to enhance cancer immunotherapy.
  • To address limitations of current immunotherapies by improving CpG stability, inducing immunogenic cell death (ICD), and activating the cGAS-STING pathway.

Main Methods:

  • Fabrication of a nanoplatform using iron oxide nanoparticles (IONPs) as a core, with G4 as a multifunctional module.
  • Integration of CpG for sustained TLR9 activation, doxorubicin (DOX) for ICD and antigen release, and IMT for cGAS-STING pathway activation.
  • Evaluation of the nanoplatform's efficacy in murine 4T1 breast cancer models.

Main Results:

  • The IONP-G4-DOX/IMT nanoplatform demonstrated enhanced CpG nuclease resistance and sustained TLR9 activation.
  • It successfully induced immunogenic cell death (ICD), released tumor antigens, and activated the cGAS-STING pathway.
  • Significant tumor suppression (79.4%) was observed in murine models with no major systemic toxicity, alongside the induction of long-term antitumor immunity.

Conclusions:

  • The developed G4-modular CpG nanoplatform offers a synergistic approach to overcome key challenges in cancer immunotherapy.
  • This strategy effectively reprograms the tumor microenvironment, enhances T cell responses, and achieves substantial tumor suppression.
  • IONP-G4-DOX/IMT presents a promising platform for advanced abscopal chemoimmunotherapy with potential for treating advanced cancers.